Arcturus Therapeutics Holdings Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Arcturus Therapeutics Holdings Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Arcturus Therapeutics Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $9.49M, a 2.42% increase year-over-year.
  • Arcturus Therapeutics Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $37.8M, a 16.9% increase year-over-year.
  • Arcturus Therapeutics Holdings Inc. annual Share-based Payment Arrangement, Expense for 2023 was $34.6M, a 13.2% increase from 2022.
  • Arcturus Therapeutics Holdings Inc. annual Share-based Payment Arrangement, Expense for 2022 was $30.6M, a 5.87% increase from 2021.
  • Arcturus Therapeutics Holdings Inc. annual Share-based Payment Arrangement, Expense for 2021 was $28.9M, a 327% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $34.6M +$4.04M +13.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $30.6M +$1.7M +5.87% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $28.9M +$22.2M +327% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $6.76M +$4.78M +241% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $1.98M +$723K +57.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.26M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.